Don’t miss the latest developments in business and finance.

USFDA classifies inspection of Cipla's Goa facility as Official Action Indicated

Image
Capital Market
Last Updated : Jan 23 2020 | 9:50 AM IST
Cipla announced that the United States Food and Drug Administration (USFDA) has classified the inspection conducted at its Goa manufacturing facility from 16-27 September 2019 as Official Action Indicated (OAI).

The Company does not believe that this will have any material impact on the US business at this stage. The Company has a strong track record of maintaining the highest standard of compliance and will work closely with the agency to comprehensively address the observations received.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 23 2020 | 9:28 AM IST

Next Story